-
Product Insights
NewNet Present Value Model: Moderna Inc’s mRNA-3927
Empower your strategies with our Net Present Value Model: Moderna Inc's mRNA-3927 report and make more profitable business decisions. Evaluating the value of drugs can be complex, involving a deep understanding of the drug, the current market and expected cash flows, expenses, and success rates at each stage of development. Fortunately, GlobalData simplifies this process with meticulously crafted, high-value, risk-adjusted NPV models that incorporate extensive drug intelligence.
-
Product Insights
NewNet Present Value Model: I-Mab’s Felzartamab
Empower your strategies with our Net Present Value Model: I-Mab's Felzartamab report and make more profitable business decisions. Evaluating the value of drugs can be complex, involving a deep understanding of the drug, the current market and expected cash flows, expenses, and success rates at each stage of development. Fortunately, GlobalData simplifies this process with meticulously crafted, high-value, risk-adjusted NPV models that incorporate extensive drug intelligence.
-
Product Insights
NewNet Present Value Model: Adaptimmune Therapeutics Plc’s ADPA-2M4CD8
Empower your strategies with our Net Present Value Model: Adaptimmune Therapeutics Plc's ADPA-2M4CD8 report and make more profitable business decisions. Evaluating the value of drugs can be complex, involving a deep understanding of the drug, the current market and expected cash flows, expenses, and success rates at each stage of development. Fortunately, GlobalData simplifies this process with meticulously crafted, high-value, risk-adjusted NPV models that incorporate extensive drug intelligence.
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Letetresgene Autoleucel in Myxoid Liposarcoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Letetresgene Autoleucel in Myxoid Liposarcoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Letetresgene Autoleucel in Myxoid Liposarcoma Drug Details: Letetresgene autoleucel (GSK-3377794) was...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Letetresgene Autoleucel in Round Cell Liposarcoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Letetresgene Autoleucel in Round Cell Liposarcoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Letetresgene Autoleucel in Round Cell Liposarcoma Drug Details: Letetresgene autoleucel...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Letetresgene Autoleucel in Synovial Sarcoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Letetresgene Autoleucel in Synovial Sarcoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Letetresgene Autoleucel in Synovial Sarcoma Drug Details: Letetresgene autoleucel (GSK-3377794) was...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Funobactam in Ventilator Associated Pneumonia (VAP)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Funobactam in Ventilator Associated Pneumonia (VAP) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Funobactam in Ventilator Associated Pneumonia (VAP) Drug Details: XNW-4107 is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Pacritinib in Angioimmunoblastic T-Cell Lymphoma (AITL)/Immunoblastic Lymphadenopathy
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Pacritinib in Angioimmunoblastic T-Cell Lymphoma (AITL)/Immunoblastic Lymphadenopathy report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Pacritinib in Angioimmunoblastic T-Cell Lymphoma (AITL)/Immunoblastic Lymphadenopathy Drug Details:...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – NKX-019 in Refractory Chronic Lymphocytic Leukemia (CLL)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - NKX-019 in Refractory Chronic Lymphocytic Leukemia (CLL) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. NKX-019 in Refractory Chronic Lymphocytic Leukemia (CLL) Drug...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Afamitresgene Autoleucel in Osteosarcoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Afamitresgene Autoleucel in Osteosarcoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Afamitresgene Autoleucel in Osteosarcoma Drug Details: ADPA-2M4 is under development for...